Cengild Medical Bhd (XKLS:0243) Other Current Receivables: RM2.78 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XKLS:0243 Cengild Medical Bhd XKLS:0243
66 GF Score
Price RM0.19
GF Value RM0.29
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is Cengild Medical Bhd Other Current Receivables?

Cengild Medical Bhd XKLS:0243 66 Other Current Receivables is RM2.78 Mil as of Mar. 2026. GuruFocus rates XKLS:0243 with a GF Score™ of 66/100 and a GF Value™ of RM0.29 (Significantly Undervalued). The stock has 5 warning signs investors should review.

Cengild Medical Bhd's Other Current Receivables for the quarter that ended in Mar. 2026 was RM2.78 Mil.

Cengild Medical Bhd's quarterly Other Current Receivables increased from Sep. 2025 (RM2.21 Mil) to Dec. 2025 (RM2.66 Mil) and increased from Dec. 2025 (RM2.66 Mil) to Mar. 2026 (RM2.78 Mil).

Cengild Medical Bhd's annual Other Current Receivables increased from Jun. 2023 (RM0.76 Mil) to Jun. 2024 (RM0.76 Mil) and increased from Jun. 2024 (RM0.76 Mil) to Jun. 2025 (RM2.09 Mil).

Cengild Medical Bhd Other Current Receivables Related Terms

Cengild Medical Bhd Other Current Receivables Historical Data

* Premium members only.

The historical data trend for Cengild Medical Bhd's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cengild Medical Bhd Other Current Receivables Chart

Cengild Medical Bhd Annual Data
Trend Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Other Current Receivables
Get a 7-Day Free Trial 0.09 0.33 0.76 0.76 2.09

Cengild Medical Bhd Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.46 2.09 2.21 2.66 2.78
XKLS:0243
66GF Score
Cengild Medical Bhd XKLS:0243
Other Current Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cengild Medical Bhd Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of RM2.78 Mil mean?
Cengild Medical Bhd (XKLS:0243) has a Other Current Receivables of RM2.78 Mil as of Mar. 2026. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Cengild Medical Bhd and its competitors.
Is Cengild Medical Bhd's Other Current Receivables too high?
Cengild Medical Bhd's current Other Current Receivables is RM2.78 Mil. Overall, Cengild Medical Bhd has a GF Score™ of 66/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Cengild Medical Bhd's Other Current Receivables compare to HCA and THC?
Cengild Medical Bhd's Other Current Receivables of RM2.78 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Healthcare Providers & Services company?
A good Other Current Receivables depends on the Healthcare Providers & Services industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Cengild Medical Bhd and its competitors. Cengild Medical Bhd's current Other Current Receivables is RM2.78 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cengild Medical Bhd stock overvalued right now?
Based on GuruFocus' analysis, Cengild Medical Bhd (XKLS:0243) is currently considered Significantly Undervalued. The stock's GF Value™ is RM0.29, compared to a current price of RM0.19 — trading 34.5% below its estimated fair value. The current Other Current Receivables is RM2.78 Mil. Cengild Medical Bhd's overall GF Score™ is 66/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For Cengild Medical Bhd (XKLS:0243), the current Other Current Receivables is RM2.78 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cengild Medical Bhd (XKLS:0243) Overvalued in 2026?

Based on GuruFocus' analysis, Cengild Medical Bhd stock appears to be undervalued. The current stock price of RM0.19 is trading 34.5% below its estimated GF Value™ of RM0.29. GuruFocus considers Cengild Medical Bhd to be Significantly Undervalued.

Key valuation signals for XKLS:0243:

  • Other Current Receivables: RM2.78 Mil
  • GF Value™: RM0.29 vs. price of RM0.19 (34.5% below fair value)
  • GF Score™: 66/100 with 5 warning signs

No single metric tells the full story. See the XKLS:0243 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cengild Medical Bhd Business Description

Address No.7, Jalan Kerinchi, Unit 2-3 & 2-4, Level 2, Nexus, Bangsar South, Kuala Lumpur, MYS, 59200
Cengild Medical Bhd is a healthcare service provider operating a medical centre specializing in the diagnosis and treatment of gastrointestinal-related diseases, oncology, gynecology services., liver diseases, and obesity. The company operates in Malaysia and has two reportable segments, Consultant Services and Medical Management Services. A substantial portion of the overall revenue is generated from its Medical Management Services segment.
66GF Score

Get the complete analysis for XKLS:0243

Other Current Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

RM0.19
Price
RM0.29
GF Value